Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C25H33N3O3S2 |
Molecular Weight | 487.678 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 3 / 3 |
E/Z Centers | 4 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CO[C@@H](\C=C\C1=CSC(=N1)C2=CSC(=N2)[C@@H](C)\C=C\C=C\C(C)C)[C@@H](C)C(\OC)=C/C(N)=O
InChI
InChIKey=XKTFQMCPGMTBMD-FYHMSGCOSA-N
InChI=1S/C25H33N3O3S2/c1-16(2)9-7-8-10-17(3)24-28-20(15-33-24)25-27-19(14-32-25)11-12-21(30-5)18(4)22(31-6)13-23(26)29/h7-18,21H,1-6H3,(H2,26,29)/b9-7+,10-8+,12-11+,22-13+/t17-,18+,21-/m0/s1
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: cytochrome bc1 oxidoreductase Sources: https://www.ncbi.nlm.nih.gov/pubmed/2753821 |
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
76706-55-3
Created by
admin on Sat Dec 16 08:13:48 GMT 2023 , Edited by admin on Sat Dec 16 08:13:48 GMT 2023
|
PRIMARY | |||
|
DTXSID10868411
Created by
admin on Sat Dec 16 08:13:48 GMT 2023 , Edited by admin on Sat Dec 16 08:13:48 GMT 2023
|
PRIMARY | |||
|
10972974
Created by
admin on Sat Dec 16 08:13:48 GMT 2023 , Edited by admin on Sat Dec 16 08:13:48 GMT 2023
|
PRIMARY | |||
|
DB04741
Created by
admin on Sat Dec 16 08:13:48 GMT 2023 , Edited by admin on Sat Dec 16 08:13:48 GMT 2023
|
PRIMARY | |||
|
6VY98BQ7NB
Created by
admin on Sat Dec 16 08:13:48 GMT 2023 , Edited by admin on Sat Dec 16 08:13:48 GMT 2023
|
PRIMARY | |||
|
Myxothiazol
Created by
admin on Sat Dec 16 08:13:48 GMT 2023 , Edited by admin on Sat Dec 16 08:13:48 GMT 2023
|
PRIMARY | |||
|
25461
Created by
admin on Sat Dec 16 08:13:48 GMT 2023 , Edited by admin on Sat Dec 16 08:13:48 GMT 2023
|
PRIMARY |
SUBSTANCE RECORD